Sale!

FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test Cost

Name: FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test Cost
SKU: TEST-1073
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the FLVCR1 gene. These mutations are known to be associated with a rare, inherited neurological disorder that affects the posterior column of the spinal cord and the retina, leading to symptoms such as impaired coordination and balance (ataxia) and progressive vision loss due to retinitis pigmentosa. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect any genetic abnormalities in the FLVCR1 gene, aiding in the accurate diagnosis of this condition. This information is crucial for understanding the prognosis, planning treatment strategies, and offering genetic counseling for affected families.

Description

FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test

Test Name: FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FLVCR1 Gene Ataxia, posterior column, with retinitis pigmentosa NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLVCR1 Gene Ataxia, posterior column, with retinitis pigmentosa.

Test Details:

The FLVCR1 gene is associated with a rare genetic disorder known as Ataxia, posterior column, with retinitis pigmentosa (APC-RP). This disorder is characterized by progressive degeneration of the posterior columns of the spinal cord, leading to ataxia (difficulty with balance and coordination) and sensory loss. Additionally, individuals with APC-RP experience retinal degeneration, resulting in vision loss and eventual blindness.

NGS genetic testing for the FLVCR1 gene can help diagnose APC-RP and aid in genetic counseling for affected individuals and their families. This test involves analyzing the DNA sequence of the FLVCR1 gene to identify any mutations or variants that may be causing the disorder. Early diagnosis and management of APC-RP can help improve quality of life for affected individuals and their families.

Test Name	FLVCR1 Gene Ataxia posterior column with retinitis pigmentosa Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FLVCR1 Gene Ataxia, posterior column, with retinitis pigmentosa NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FLVCR1 Gene Ataxia, posterior column, with retinitis pigmentosa
Test Details	The FLVCR1 gene is associated with a rare genetic disorder known as Ataxia, posterior column, with retinitis pigmentosa (APC-RP). This disorder is characterized by progressive degeneration of the posterior columns of the spinal cord, leading to ataxia (difficulty with balance and coordination) and sensory loss. Additionally, individuals with APC-RP experience retinal degeneration, resulting in vision loss and eventual blindness. NGS genetic testing for the FLVCR1 gene can help diagnose APC-RP and aid in genetic counseling for affected individuals and their families. This test involves analyzing the DNA sequence of the FLVCR1 gene to identify any mutations or variants that may be causing the disorder. Early diagnosis and management of APC-RP can help improve quality of life for affected individuals and their families.